reported a median PFS of 144 months across 60 PATZ1-fused brain tumors but only 31 months (range: 6–144) for EWSR1::PATZ1 fusion cases confirmed by RNA sequencing (25). This evidence concerns the gene PATZ1 and brain neoplasm.